Publications by authors named "David Erbe"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

2,579

Total Likes

30

Extended Reach

111,517

Social Features

17
N
Neurofilament Light Chain as a Biomarker of Hereditary Transthyretin-Mediated Amyloidosis.
Simina Ticau, Gautham V Sridharan, Shira Tsour, William L Cantley, Amy Chan, Jason A Gilbert, David Erbe, Emre Aldinc, Mary M Reilly, David Adams

Neurology· January 2021

Videos about Article: user user

2 1 2 14

View All Article and Social Media Activity
P
Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1: A Placebo-Controlled Randomized Clinical Trial.
Yaacov Frishberg, Georges Deschênes, Jaap W Groothoff, Sally-Anne Hulton, Daniella Magen, David V Erbe

Clin J Am Soc Nephrol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry.
Margaret M Parker, Scott M Damrauer, Catherine Tcheandjieu, David Erbe, Emre Aldinc

Sci Rep· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transthyretin-stabilising mutation T119M is not associated with protection against vascular disease or death in the UK Biobank.
Margaret M Parker, Simina Ticau, James Butler, David Erbe, Madeline Merkel

Amyloid· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterising a healthy adult with a rare HAO1 knockout to support a therapeutic strategy for primary hyperoxaluria.
Tracy L McGregor, Karen A Hunt, Elaine Yee, Dan Mason, Paul Nioi, David V Erbe

Elife· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction in urinary oxalate excretion in mouse models of Primary Hyperoxaluria by RNA interference inhibition of liver lactate dehydrogenase activity.
Kyle D Wood, Ross P Holmes, David Erbe, Abigail Liebow, Sonia Fargue

Biochim Biophys Acta Mol Basis Dis· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria.
Abigail Liebow, Xingsheng Li, Timothy Racie, Julia Hettinger, Brian R Bettencourt, David Erbe, William Querbes

J Am Soc Nephrol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crystal structure of an HSA/FcRn complex reveals recycling by competitive mimicry of HSA ligands at a pH-dependent hydrophobic interface.
Michael M Schmidt, Sharon A Townson, Amy J Andreucci, Bracken M King, Emily B Schirmer, David V Erbe

Structure· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A zymogen-like factor Xa variant corrects the coagulation defect in hemophilia.
Lacramioara Ivanciu, Raffaella Toso, Paris Margaritis, Giulia Pavani, Haein Kim, David V Erbe

Nat Biotechnol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PPARdelta Agonism for the Treatment of Obesity and Associated Disorders: Challenges and Opportunities.
Mylène Perreault, David V Erbe, James F Tobin

PPAR Res· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
H6PDH interacts directly with 11beta-HSD1: implications for determining the directionality of glucocorticoid catalysis.
Yan-ling Zhang, Xiaotian Zhong, Zheni Gjoka, Yuanhong Li, Wayne Stochaj, David Erbe

Arch Biochem Biophys· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent.
Dean R Artis, Jack J Lin, Chao Zhang, Weiru Wang, Upasana Mehra, David Erbe

Proc Natl Acad Sci U S A· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-based optimization of protein tyrosine phosphatase-1 B inhibitors: capturing interactions with arginine 24.
Zhao-Kui Wan, Jinbo Lee, Rajeev Hotchandani, Alessandro Moretto, Eva Binnun, David V Erbe

ChemMedChem· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-based optimization of protein tyrosine phosphatase 1B inhibitors: from the active site to the second phosphotyrosine binding site.
Douglas P Wilson, Zhao-Kui Wan, Wei-Xin Xu, Steven J Kirincich, Bruce C Follows, David V Erbe

J Med Chem· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An enzyme-linked immunosorbent assay to measure insulin receptor dephosphorylation by PTP1B.
Yan-Ling Zhang, May Tam, Steve Kirincich, Zhao-Kui Wan, Doug Wilson, David V Erbe

Anal Biochem· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probing acid replacements of thiophene PTP1B inhibitors.
Zhao-Kui Wan, Bruce Follows, Steve Kirincich, Douglas Wilson, Eva Binnun, David Erbe

Bioorg Med Chem Lett· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular activation of PPARgamma by angiotensin II type 1-receptor antagonists.
David V Erbe, Katherine Gartrell, Yan-Ling Zhang, Vipin Suri, Steven J Kirincich

Vascul Pharmacol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monocyclic thiophenes as protein tyrosine phosphatase 1B inhibitors: capturing interactions with Asp48.
Zhao-Kui Wan, Jinbo Lee, Weixin Xu, David V Erbe, Diane Joseph-McCarthy

Bioorg Med Chem Lett· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ertiprotafib improves glycemic control and lowers lipids via multiple mechanisms.
David V Erbe, Suyue Wang, Yan-Ling Zhang, Kimberly Harding, Leslie Kung

Mol Pharmacol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibodies to B7.1 define the GFCC'C" face of the N-terminal domain as critical for co-stimulatory interactions.
Suyue Wang, Geertruida M Veldman, Mark Stahl, Yuzhe Xing, James F Tobin, David V Erbe

Immunol Lett· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small molecule ligands define a binding site on the immune regulatory protein B7.1.
David V Erbe, Suyue Wang, Yuzhe Xing, James F Tobin

J Biol Chem· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis